• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CT检查中肾功能不全患者的对比剂肾病(CIN)

Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.

作者信息

Fukushima Yasuhiro, Miyazawa Hitomi, Nakamura Junpei, Taketomi-Takahashi Ayako, Suto Takayuki, Tsushima Yoshito

机构信息

Department of Radiology, Gunma University Hospital, 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan.

Division of Clinical Radiology Service, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

出版信息

Jpn J Radiol. 2017 Aug;35(8):427-431. doi: 10.1007/s11604-017-0649-4. Epub 2017 May 20.

DOI:10.1007/s11604-017-0649-4
PMID:28528465
Abstract

PURPOSE

To investigate the incidence and risk factors of contrast induced nephropathy (CIN) after contrast enhanced (CE) computed tomography (CT) in patients with renal dysfunction.

MATERIALS AND METHODS

Two hundred sixteen inpatients with estimated glomerular filtration rates (eGFR) <60 ml/min/1.73 m underwent CE CT using iodine doses of 420 or 480 mg I/kg. Data of all enrolled patients was collected for baseline serum creatinine level (SCr), post-CE CT SCr within 3 days after CE CT, and conditions considered risk factors for CIN [renal dysfunction, contrast media dose, advanced age, diabetes mellitus, no intravenous hydration, cardiac dysfunction (left ventricular ejection fraction <60%) and intensive-care unit (ICU) admission]. CIN was defined as an increase in SCr level of more than 0.5 mg/dl or more than 25% from baseline within 3 days post-CE CT without any other identifiable cause of acute kidney injury.

RESULTS

The incidence of CIN was 11/216 (5.1%) and was associated with cardiac dysfunction [odds ratio (OR) 6.540; 95% confidence interval (CI) 1.090-39.300; p = 0.040] and ICU admission (OR 11.500; 95% CI 2.050-64.100; p = 0.005).

CONCLUSION

Our results suggested that cardiac dysfunction and ICU admission may be risk factors for CIN in patients with preexisting renal dysfunction.

摘要

目的

探讨肾功能不全患者在对比增强计算机断层扫描(CT)后对比剂肾病(CIN)的发生率及危险因素。

材料与方法

216例估计肾小球滤过率(eGFR)<60 ml/min/1.73 m²的住院患者接受了碘剂量为420或480 mg I/kg的对比增强CT检查。收集所有入组患者的基线血清肌酐水平(SCr)、对比增强CT后3天内的对比增强CT后SCr以及被认为是CIN危险因素的情况[肾功能不全、造影剂剂量、高龄、糖尿病、无静脉补液、心功能不全(左心室射血分数<60%)和入住重症监护病房(ICU)]。CIN定义为对比增强CT后3天内SCr水平较基线升高超过0.5 mg/dl或超过25%,且无其他可识别的急性肾损伤原因。

结果

CIN的发生率为11/216(5.1%),与心功能不全[比值比(OR)6.540;95%置信区间(CI)1.090 - 39.300;p = 0.040]和入住ICU(OR 11.500;95% CI 2.050 - 64.100;p = 0.005)相关。

结论

我们的结果表明,心功能不全和入住ICU可能是已有肾功能不全患者发生CIN的危险因素。

相似文献

1
Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.CT检查中肾功能不全患者的对比剂肾病(CIN)
Jpn J Radiol. 2017 Aug;35(8):427-431. doi: 10.1007/s11604-017-0649-4. Epub 2017 May 20.
2
Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.通过心脏导管插入术后次日的血清肌酐水平预测造影剂肾病
J Cardiol. 2016 Nov;68(5):412-418. doi: 10.1016/j.jjcc.2015.10.016. Epub 2015 Dec 18.
3
Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.肾移植患者静脉注射低渗碘造影剂后急性肾损伤、透析和移植物丢失的发生率。
Abdom Radiol (NY). 2016 Nov;41(11):2182-2186. doi: 10.1007/s00261-016-0827-3.
4
Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors.接受计算机断层扫描的重症监护患者中对比剂肾病的发生率及危险因素的患病率。
Anaesth Intensive Care. 2009 Nov;37(6):968-75. doi: 10.1177/0310057X0903700613.
5
Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.慢性肾脏病患者 CT 检查后对比剂肾病的发生率和结局:质量改进报告。
Am J Kidney Dis. 2010 Jun;55(6):1018-25. doi: 10.1053/j.ajkd.2009.10.057. Epub 2010 Jan 25.
6
Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.临床因素对低估计肾小球滤过率患者应用静脉碘普罗胺低渗造影剂后发生造影剂肾病风险的影响。
AJR Am J Roentgenol. 2019 Nov;213(5):W188-W193. doi: 10.2214/AJR.19.21424. Epub 2019 Jul 3.
7
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.对比剂诱导的肾毒性与静脉应用低渗碘对比剂:基于估算肾小球滤过率的危险分层。
Radiology. 2013 Sep;268(3):719-28. doi: 10.1148/radiol.13122276. Epub 2013 Apr 11.
8
Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.接受增强计算机断层扫描的活动性癌症患者的对比剂肾病
Support Care Cancer. 2016 Mar;24(3):1011-7. doi: 10.1007/s00520-015-2875-6. Epub 2015 Aug 4.
9
Risk factors for acute kidney injury in the elderly undergoing contrast-enhanced computed tomography in the emergency department.急诊科行增强 CT 检查的老年患者发生急性肾损伤的危险因素。
J Chin Med Assoc. 2013 May;76(5):271-6. doi: 10.1016/j.jcma.2013.01.007. Epub 2013 Mar 21.
10
Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.II型糖尿病患者心脏导管插入术后对比剂肾病的发生率及危险因素:一项针对埃及患者的研究。
Ren Fail. 2014 Mar;36(2):191-7. doi: 10.3109/0886022X.2013.843400. Epub 2013 Oct 21.

引用本文的文献

1
Feasibility study of "double-low" scanning protocol combined with artificial intelligence iterative reconstruction algorithm for abdominal computed tomography enhancement in patients with obesity.“双低”扫描方案联合人工智能迭代重建算法用于肥胖患者腹部CT增强扫描的可行性研究
BMC Med Imaging. 2025 Jul 9;25(1):276. doi: 10.1186/s12880-025-01808-9.
2
Contrast induced nephropathy in women with infertility undergoing hysterosalpingography.子宫输卵管造影术所致不孕症女性的对比剂肾病
Reprod Biol Endocrinol. 2024 Dec 19;22(1):156. doi: 10.1186/s12958-024-01334-3.
3
Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses.

本文引用的文献

1
Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.静脉造影剂暴露不是透析或死亡的独立危险因素。
Radiology. 2014 Dec;273(3):714-25. doi: 10.1148/radiol.14132418. Epub 2014 Sep 9.
2
Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.静脉造影剂致急性肾损伤的风险:基于基线估算肾小球滤过率的倾向评分匹配研究。
Radiology. 2014 Apr;271(1):65-73. doi: 10.1148/radiol.13130775. Epub 2014 Jan 16.
3
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.
评估冠状动脉介入治疗后对比剂诱导肾病的生物标志物:荟萃分析的伞状评价。
Eur J Med Res. 2024 Apr 1;29(1):210. doi: 10.1186/s40001-024-01782-y.
4
A novel risk factor of contrast associated acute kidney injury in patients after enhanced computed tomography: a retrospective study.增强 CT 后患者对比剂相关急性肾损伤的新危险因素:一项回顾性研究。
PeerJ. 2022 Oct 20;10:e14224. doi: 10.7717/peerj.14224. eCollection 2022.
5
Artificial Intelligence Algorithm-Based Computed Tomography Image in Assessment of Acute Renal Insufficiency of Patients Undergoing Percutaneous Coronary Intervention.基于人工智能算法的计算机断层扫描图像在评估行经皮冠状动脉介入治疗的急性肾功能不全患者中的应用。
Contrast Media Mol Imaging. 2022 Feb 28;2022:2214583. doi: 10.1155/2022/2214583. eCollection 2022.
6
Post-Contrast Acute Kidney Injury in Patients with Various Stages of Chronic Kidney Disease-Is Fear Justified?慢性肾脏病不同分期患者的对比剂后急性肾损伤:有理由感到恐惧吗?
Toxins (Basel). 2021 Jun 1;13(6):395. doi: 10.3390/toxins13060395.
7
Intravenous contrast use and acute kidney injury: a retrospective study of 1,238 inpatients undergoing computed tomography.静脉造影剂的使用与急性肾损伤:对1238例接受计算机断层扫描的住院患者的回顾性研究
Radiol Bras. 2021 Mar-Apr;54(2):77-82. doi: 10.1590/0100-3984.2020.0018.
8
Does Exposure to Computed Tomography Contrast Media Increase Risk of End-Stage Renal Disease?计算机断层扫描造影剂暴露是否会增加终末期肾病的风险?
Med Sci Monit. 2020 Mar 23;26:e921303. doi: 10.12659/MSM.921303.
9
Guideline on the use of iodinated contrast media in patients with kidney disease 2018.《2018年肾病患者使用碘化造影剂指南》
Jpn J Radiol. 2020 Jan;38(1):3-46. doi: 10.1007/s11604-019-00850-2.
10
Guideline on the use of iodinated contrast media in patients with kidney disease 2018.《2018年肾病患者使用碘化造影剂指南》
Clin Exp Nephrol. 2020 Jan;24(1):1-44. doi: 10.1007/s10157-019-01750-5.
2012年肾病患者使用碘化造影剂指南:摘要版。日本肾脏病学会(JSN)、日本放射学会(JRS)和日本循环系统学会(JCS)联合工作组
Jpn J Radiol. 2013 Aug;31(8):546-84. doi: 10.1007/s11604-013-0226-4.
4
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.对比剂诱导的肾毒性与静脉应用低渗碘对比剂:基于估算肾小球滤过率的危险分层。
Radiology. 2013 Sep;268(3):719-28. doi: 10.1148/radiol.13122276. Epub 2013 Apr 11.
5
Investigation of the freely available easy-to-use software 'EZR' for medical statistics.医学统计学中免费易用软件 EZR 的调查研究。
Bone Marrow Transplant. 2013 Mar;48(3):452-8. doi: 10.1038/bmt.2012.244. Epub 2012 Dec 3.
6
Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure.健康受试者、精英运动员和充血性心力衰竭患者的心血管磁共振测量心输出量和心指数。
J Cardiovasc Magn Reson. 2012 Jul 28;14(1):51. doi: 10.1186/1532-429X-14-51.
7
Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?静脉注射造影剂所致肾毒性:其医疗风险真的如我们所认为的那般大吗?
Radiology. 2010 Jul;256(1):21-8. doi: 10.1148/radiol.10092000.
8
Risk for contrast nephropathy in patients undergoing coronarography.行冠状动脉造影术患者的对比剂肾病风险。
Artif Organs. 2010 Jun;34(6):E193-9. doi: 10.1111/j.1525-1594.2009.00984.x. Epub 2010 May 7.
9
Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.慢性肾脏病患者 CT 检查后对比剂肾病的发生率和结局:质量改进报告。
Am J Kidney Dis. 2010 Jun;55(6):1018-25. doi: 10.1053/j.ajkd.2009.10.057. Epub 2010 Jan 25.
10
Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.门诊患者行增强计算机断层扫描后对比剂肾病的发生率。
Clin J Am Soc Nephrol. 2010 Jan;5(1):4-9. doi: 10.2215/CJN.05200709. Epub 2009 Dec 3.